Journal article
Clinical Correlates and Outcomes of Dual Basiliximab and Antithymocyte Globulin Induction in Kidney Transplant Recipients: A National Study
Transplantation direct, Vol.7(8), pp.e736-e736
07/23/2021
DOI: 10.1097/TXD.0000000000001190
PMCID: PMC9276156
PMID: 35836670
Abstract
Supplemental Digital Content is available in the text.
The unplanned use of dual induction therapy with interleukin-2 receptor-blocking antibodies (IL2rAb) and antithymocyte globulin (ATG) may portend adverse outcomes.
Details
- Title: Subtitle
- Clinical Correlates and Outcomes of Dual Basiliximab and Antithymocyte Globulin Induction in Kidney Transplant Recipients: A National Study
- Creators
- Ngan N. Lam - University of CalgaryRachel Jeong - University of CalgaryRobert R. Quinn - University of CalgaryPietro Ravani - University of CalgaryHuiling Xiao - Saint Louis UniversityMara McAdams-DeMarco - Johns Hopkins UniversityDavid A. Axelrod - University of IowaMark A. Schnitzler - Saint Louis UniversityJon J. Snyder - Hennepin Healthcare Research InstituteKrista L. Lentine - Saint Louis University
- Resource Type
- Journal article
- Publication Details
- Transplantation direct, Vol.7(8), pp.e736-e736
- DOI
- 10.1097/TXD.0000000000001190
- PMID
- 35836670
- PMCID
- PMC9276156
- NLM abbreviation
- Transplant Direct
- ISSN
- 2373-8731
- eISSN
- 2373-8731
- Publisher
- Lippincott Williams & Wilkins
- Language
- English
- Date published
- 07/23/2021
- Academic Unit
- Surgery
- Record Identifier
- 9984322956102771
Metrics
7 Record Views